Log In
BCIQ
Print this Print this
 

BCR-ABL tyrosine kinase

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting BCR-ABL tyrosine kinase

BCIQ
Print ChartPrint this
Marketed, 1 Marketed, 5 Registration, 1 Phase II, 1 Phase II, 5 Phase II, 1 Phase I, 1 Phase I, 4 Preclinical, 2 Preclinical, 1 Preclinical, 6 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase IIRegistrationMarketed
Autoimmune

1

-

1

-

-

Cancer

6

4

5

-

5

Cardiovascular

-

-

-

1

-

Hematology

-

-

-

-

1

Infectious

1

-

-

-

-

Neurology

2

1

-

-

-

Renal

-

-

1

-

-




 Products Targeting BCR-ABL tyrosine kinase
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

9

$163.7M

$233.9M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today